SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

01 Nov 2023 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended September 2023, as compared to corresponding quarter of last year.The Company to register a -62.85%  fall in the net profit for the quarter ended September 2023.A decline of 7.21 millions was observed in the OP in the quarter ended September 2023 from 19.41 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 7.53 -15.37 -148.99 8.28 21.62 -61.70
Other Income 7.57 20.50 -63.07 7.57 20.50 -63.07 0.00 0.07 0.00
PBIDT 7.21 19.41 -62.85 11.27 3.51 221.08 4.56 -0.08 -5800.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 7.21 19.41 -62.85 11.27 3.51 221.08 4.56 -0.08 -5800.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 7.21 19.41 -62.85 11.27 3.51 221.08 4.56 -0.08 -5800.00
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 7.21 19.41 -62.85 11.27 3.51 221.08 4.56 -0.08 -5800.00
Equity 652.60 652.60 0.00 652.60 652.60 0.00 652.60 652.60 0.00
PBIDTM(%) 0.00 0.00 0.00 149.67 -22.84 -755.38 55.07 -0.37 -14984.46

Biogen Pharmachem Share Price

0.47 0.01 (2.17%)
06-May-2026 14:33 View Price Chart
Peers
Company Name CMP
Redington 222.50
Adani Enterprises 2540.75
Amrapali Industries 18.22
Rashi Peripheral 503.10
PDS 286.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×